• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Intracranial pressure monitoring market Companies

    ID: MRFR/MED/0232-CR
    129 Pages
    Kinjoll Dey
    February 2021

    Intracranial pressure (ICP) monitoring is a critical aspect of neurocritical care, particularly in the management of conditions such as traumatic brain injury, stroke, and certain neurological disorders. Monitoring ICP allows healthcare professionals to assess and manage brain health by measuring the pressure inside the skull.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Intracranial Pressure Monitoring Market Research Report - Forecast to 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Intracranial pressure monitoring market

    Intracranial Pressure Monitoring Key Companies

     


    Latest Intracranial Pressure Monitoring Companies Update:

    Medtronic (US) Acquired Rafale Medical in October 2023, gaining access to Rafale's innovative NeuroGuard ICP monitoring system with its unique sensor design. This acquisition strengthens Medtronic's position in the market and potentially paves the way for further innovation in ICP monitoring technology.


    Brainlab (Germany) Received FDA clearance for its iSAM ICP monitoring system in June 2023. This system offers real-time pressure insights directly integrated into Brainlab's surgical navigation platform, enhancing workflow efficiency and potentially improving surgical outcomes.


    Raumedic (Germany) Announced the CE marking of its Raumed Home ICP device in December 2023, marking a significant step towards home-based ICP monitoring for patients with hydrocephalus. This development could increase accessibility and quality of life for patients.


    Natus Medical Incorporated (US) Completed the acquisition of Micromed Holding SAS ("Micromed") in November 2022, strengthening their neurophysiology portfolio and potentially expanding their reach in the ICP monitoring market.


    Brain4care (Brazil) Developed a non-invasive ICP monitoring method using high blood pressure measurements, approved by FAPESP in July 2023. This innovative approach could offer affordable and accessible ICP monitoring options, particularly in resource-limited settings.


    List of Intracranial Pressure Monitoring Key companies in the market


    • Medtronic (Ireland)




    • Codman & Shurtleff Inc. (U.S.)




    • RAUMEDIC AG (Germany)




    • Spiegelberg GmbH & Co. KG (Germany)




    • Natus Medical Incorporated (U.S.)




    • Gaeltec Devices (U.K.)




    • Third Eye Diagnostics (U.S.)




    • Vivonics Inc. (U.S.)




    • DePuy Synthes (U.S.)